CONTINUOUS E F F I C I E N T TRACHEOBRON-
chid toilet after thoracotomy is universally recognized as an important feature of patient care to promote rapid mcovery of respiratory stability and prevent complication. This is accomplished by unhesitating application of vigorous methods to stimulate f q u c n t cough and deep breathing. The contrast between the aggmsive attitude toward respiratory economy of the post-thoracotomy patient and the sometimes semi-neglectful attitude toward the postseliotomy patient, may be strilingly demonstrated by the incidence of roent-.genographic atelectasis occumng in these two groups of surgical patienh A p d iinary pmspectivc roentgenographic survey of abdominal surgery cases attended at this hospital revealed a 50 per cent inddence of pulmonary atelectasis.' This unacceptably high rate of pulmonary complication was favorably influenced by adoption of an aggressive preventive attitude which included administration of the mucolytic agent acetylcysteine. By i m p k o n , the incidence of poet-thoracotomy atelectasis did not seem to be alarming; however, this investigation was undertaken to more accurately determine the rate of occurrence, and to -the clinical usefulness of the mucolytic agent, acetylcysteine, employed an adjunct in management of thoracic surgical patients. 
MATERIAL AND METHODS

One
2'39
surgical procedures were prospectively studied and the postoperative care altered to include administration of acetylcysteine. Immediately, as thoracotomy was completed, a PE 50 polyethylene catheter was percutaneously placed in the trachea as described by Radigan and King.' Acetylcysteine was administered as a 10 per cent solution through the cathctcr 2 ml every two houn the first day and with decreasing frequency thereafter for three to five days until the pleural drainage t u b a were removed or drainage subsided. Catheter placement failures and complications among the treated patients were insignificant; however, premature dislodgement did occur occasionally. The mucolytic agent was administered as an aemsol by intermittent positive prssure breathing apparatus if the catheter was displaced or failed to function.
Upon completion of the aforementioned series of cases, postoperative management was modified to permit administration of the mucolytic agent by intermittent positive breathing apparatus. Therefore, in the final 30 patients studied to elicit the presence of contralateral pulmonary atelectasis, placement of an intratracheal catheter was not employed; however, the amount and f q u e n c y of 10 per cent acctylcystcine administ& was not changed. RESULTS The relationship between the various surgical procedures and incidence of contralateral pulmonary atelectasis in the cases studied is presented in Fig. 1. . 4 higher incidence of atelectasis m e d to attend lobectomy, but with e q u a1 frequency whether patients received acetylcysteine or not. The addition of the mucolytic agent administered in the mannen described did not influence the incidence of atelectasis remarkably, either within groups of patients having similar operations, or between the trtated and untreated groups. For the total serics of 198 operative procedures studied, a 14 per cent incidence of contralateral, subacgmental roentgenographic atelectasis was recorded. Contralateral lobar atelectasis was not ohxrved; however, ipsilateral collapse of a complete lobe was noted on two occasions. per cent, while the incidence of contralateral atelectasis among thoramtomized patients was considerably lm. Although t h e are not comparable ob~e~ations, the same nursing pemnnel administered p t o p e rative care to all of the patients. The addition of therapeutic muwlysL after abdominal surgery resulted in a dramatic reduction in pulmonary atelectasis, whereas the same dramatic effect was not demonstrated after thoracotomy. Although it was hoped that a reduced incidence of atelectasis after thoracotomy might result from the addition of mucolytic therapy, the outcome was not completely unexpected. The attention of both physicians and nurses has always been oriented to the respiratory function of the thoracic surgical patient.
Prompt elimination of tracheobronchial secretions after thoracotomy is of greatest importance. This can usually be accomplished by f r e q u e n t asdsted coughing, transnasal tracheal aspirations and occasionally bronchmopy in a difficult situation. The addition of a mucolytic agent to promote rapid transport of secretions and increase effectual coughing should be helpful. AcetylcrJt~e was selected for this purpose because reported clinical experiences have been encouraging; it docs have AND MERRIGAN a distinct mucolytic property and it docs not have a deleterious effect on pulmonary surfactant.'" This study did not demonstrate a reduction in incidence of contralateral atelecta* in the group of c a m receiving acetylcysteine. However, the nursing care of treated casa was simpliied. Direct intratracheal administration of the mucolytic agent frequently stimulated effective secretion-clearing cough and transnasal tracheal aspiration was less often required. However, some patients complained of nausea and anorexia, attributed to the constant offensive odor and taste of acetylclsteine administered in this way. Greater patient acceptance of the mucolytic agent given by intermittent positive prcssure breathing apparatus was achieved. The apparent therapeutic effectiveness of the agent was not compromised by this modification of management.
The necessiv for intermittent deep inspiration, sighing, to avoid hypoventilatory pulmonary atelectasis is widely recognized by anesthesi~lo~isu.' However, postoperative patients find it difficult to breath deep ly even when encouraged to do so. Logically, intermittent positive prasure misted breathing should overcome resistance to full inspiration. However, clinical investigations directed toward eliminating postoperative atelectasis employing assisted ventilation did not demonstrate substantial benefit."" Intermittent positive p m r e breathing was freely employed in the p u p of cases reviewed retrospectively who did not receive acetylcysteine. Direct intratracheal instillation of the mucolytic agent was employed to eliminate any complimentary benefit of positive pressure breathing in the initial evaluation of mucolysis. U p o n completion of the comparative study, the program of management was modified to take advantage of the potential benefits of both ventilatory a e t a n c e and mucolysis.
It is interesting to observe that through this entire period of special interest and emphasis on postoperative pulmonary atelectasis, the incidence of this complication occurring in the contralateral lung has remained constant. Speculation as to the explanation for this refractory incidence is tempting. Presumably, recognition of the magnitude of the problem and appropriate therapeutic measures are sufficient to avoid progression to more serious and threatening complications. At the p m t time we reserve placement of a transtracheal catheter for patients in whom a difficult problem in tracheobronchial toilet is anticipated or develops in the postoperative period. SUMMARY A comparative investigation of the incidence of contralateral roentgenographic pulmonary atelectasis was made in three groups of post-thoracotomy cases. The first 84 cases received adequate aftercare with good tracheobronchial toilet without emphasis on mucolysis. The second 84 c a w received acetylcpteine administered by direct intratracheal instillations in 10 per cent concentration in addition to accepted aftercare. The third group of 30 cases received the mucolytic agent administered by intermittent positive pressure breathing apparatus. The incidence of contralateral pulmonary atelectasis for the total series of cass was 14 per cent and did not vary signir~canty between the groups studied. The incidence of atelectasis is recognizably related to moment by moment supenision of tracheobronchial toilet after thoracotom!., rather than a specific technique or therapeutic agent. However, the addition of acetylcysteine may be a valuable adjunctive agent to promote easier and more rapid elimination of undesirable secretions. R e s u~e n En tres grupos de post-toracotomhados w practic6 la investigaci6n sistemltica radiol6gica de la atelectasia contralateral. Los 84 primems recibiemn tratamienro postoperatorio adecuado con efectiva toilet traqumbronquial, sin insistencia en el empleo de agentcs mucoliticos. Lo, segundos 84 caws rccibieron acetilcysteina admininvada por instilaci6n directa traqueo-bronquial en concentraci6n al d i n por ciento, ademis de la debida atenci6n postoperatorio. El tercer grupo de 30 cams recibi6 el agente mucolitico adminirtrado por medio del aparato de respiraci6n a presi6n ~O S~U M intermitente. La incidmcia de atelectasia pulmonar contralateral m el total de casos fue de un catorce por ciento, sin variaciones significativas entre 10s distintos grupos. La incidencia de atelectasia esth relacionada con la atenci6n sostenida a la toilet traqueobmnquial en el postoperatorio de Ion traqueotomizados, m& bien que con tCcnica alguna o con el empleo de determinado agente terapCutico. Sin embargo, la adici6n de acetylcisteina puede ser htil en cuanto a facilitar la climinaci6n rlpida de secreciones perjudiciales. Dar Vorkommen einer Atelektase ist wie leicht N erkennen ist, eng verkniipft mit der pauwnlosen Ubewachttng der Toilette des Trachmbronchialhaumes nach der Thorakotomie und m a r in weit starkerem Ausmap als die im einzelnen angewandte Technik oder das Heilmittel angeht.
ZUSAMMENFASSUNG
Es kann jedoch der Zusatz von Acetylcywein eine weetvolle Untentiiuung darstellen, um eine leichtere und rchellere Elimination unemiinschter Sekretbildungen zu fordem. 
